Industry Insights

  1. Biopharma Drug Development Workflow And Techniques 1/3/2024

    Drug development is a long and complex process, and every step has specific goals. Explore the relevant objectives and techniques used in each stage of antibody drug development.

  2. Hidden Sensitive Data Liability: Why Legacy Web Forms Put Life Sciences Organizations At Critical Risk 11/21/2025

    Many life science organizations collect sensitive data through outdated web forms, exposing companies to critical vulnerabilities, data breaches, regulatory penalties, and more.

  3. 3 Ways To Survive The Shifts In Life Sciences 1/6/2021

    Over the past 20 years, the life sciences industry has undergone massive changes, and new software and partners have emerged. There are three key ways that business can serve the dynamic needs of modern drug development.

  4. Standardized And Structured Data Equate To Smarter Decision-Making 8/1/2024

    Poor data capture can result in rework, repetition and delayed submission. Improve data management via data standards and structured data.

  5. Oxygen Sensitive Drug Products

    Primary packaging is thought of as the first line of defense against the negative effects of oxygen. This article highlights other areas to consider that can help avoid drug quality degradation.

  6. Testing And Selecting A Detergent Cleaning System 4/26/2023

    Testing and selecting an aqueous cleaning system involves a seven-step process. In this chapter of The Aqueous Cleaning Handbook, follow along as we walk through those steps to help you optimize your cleaning process.

  7. The Coevolution Of The Single-Use And Biopharmaceutical Industries

    Learn more about the evolution of one company's solutions for biopharmaceutical manufacturing and accelerating market entrance using single-use technology.

  8. When Biopharma Automation Projects Fail: Averting Disaster 1/25/2021

    Automation does not always result in success, and poor automation can be as damaging to the pharmaceutical organization as no automation at all. This article addresses what happens when automation goes wrong and how mistakes can be avoided by adopting a risk-centric approach.

  9. The US Drug Pricing System Needs to Be Fixed 6/16/2021

    Reforms to the U.S. drug pricing environment are required, but to improve patients’ health outcomes, reforms must be grounded in a comprehensive understanding of the current drug pricing system. Otherwise, policymakers will make things worse, not better.

  10. FDA Seeks Comment On Delaying, Denying, Limiting, Refusing Inspections 1/9/2023

    The FDA has released for public comment a proposed draft guidance, Circumstances that Constitute Delaying, Denying, Limiting, or Refusing a Drug or Device Inspection Revision 1. The guidance shares examples of reasonable and unreasonable circumstances. Submit public comments by February 14, 2023.